Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

8.270
-0.180-2.13%
Volume:6.89M
Turnover:56.55M
Market Cap:6.84B
PE:291.35
High:8.730
Open:8.600
Low:8.030
Close:8.450
Loading ...

Press Release: Harbour BioMed Reports Full Year 2024 Financial Results

Dow Jones
·
31 Mar

Harbour BioMed Shares Soar on News of AstraZeneca Collaboration

Dow Jones
·
24 Mar

Stock Track | HBM Holdings Soars 11.62% on Strategic Partnership with AstraZeneca

Stock Track
·
24 Mar

HBM Holdings Jumps 10% As It Partners with AstraZeneca for Strategic Growth

Tiger Newspress
·
24 Mar

BRIEF-HBM Holdings To Issue To Astrazeneca Holdings Subscription Shares

Reuters
·
21 Mar

BRIEF-Harbour Biomed Enters Into Global Strategic Collaboration With Astrazeneca

Reuters
·
21 Mar

Hbm Holdings Ltd - Harbour Biomed to Receive $175 Million Upfront and up to $4.4 Billion in Milestones

THOMSON REUTERS
·
21 Mar

Harbour Biomed Enters Into Global Strategic Collaboration With AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

THOMSON REUTERS
·
21 Mar

Hbm Holdings Ltd - AstraZeneca to Acquire 9.15% Newly Issued Shares of Harbour Biomed

THOMSON REUTERS
·
21 Mar

Hbm Holdings - to Issue to AstraZeneca Holdings Subscription Shares at US$1.38 per Share

THOMSON REUTERS
·
21 Mar

Harbour Biomed Appoints DR. Ian Y. Liu as Global Head of Legal

THOMSON REUTERS
·
11 Mar

Harbour Biomed Appoints Michael D. Patten as Chief Strategy Officer

THOMSON REUTERS
·
11 Mar

Press Release: Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal

Dow Jones
·
11 Mar

Press Release: Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

Dow Jones
·
11 Mar

Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%

MT Newswires Live
·
06 Mar

HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody

MT Newswires Live
·
06 Mar

BUZZ-HK-listed Hbm at 3-year peak on getting paid for license deal

Reuters
·
06 Mar

BRIEF-HBM Holdings Says Upfront Payment Received Under License Agreement With Windward Bio AG

Reuters
·
06 Mar

Hbm Holdings - Upfront Payment Received Under License Agreement With Windward Bio Ag for Hbm9378/Skb378

THOMSON REUTERS
·
06 Mar

HBM Joint Venture Strikes Licensing Deal to Advance Novel CRH Therapies

MT Newswires Live
·
26 Feb